Cargando…
MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells
INTRODUCTION: The multiple biological responses to estrogens are mainly mediated by the classical estrogen receptors ERα and ERβ, which act as ligand-activated transcription factors. ERα exerts a main role in the development of breast cancer; therefore, the ER antagonist tamoxifen has been widely us...
Autores principales: | Lappano, Rosamaria, Santolla, Maria Francesca, Pupo, Marco, Sinicropi, Maria Stefania, Caruso, Anna, Rosano, Camillo, Maggiolini, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496129/ https://www.ncbi.nlm.nih.gov/pubmed/22251451 http://dx.doi.org/10.1186/bcr3096 |
Ejemplares similares
-
Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts
por: Pupo, Marco, et al.
Publicado: (2012) -
A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models
por: Lappano, Rosamaria, et al.
Publicado: (2015) -
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)
por: De Francesco, Ernestina Marianna, et al.
Publicado: (2013) -
GPER Function in Breast Cancer: An Overview
por: Lappano, Rosamaria, et al.
Publicado: (2014) -
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2019)